Home › Categories › Health & Wellness› 7 July – LUCID-B Study: Interim Report 2

7 July – LUCID-B Study: Interim Report 2.pdf

LUCID-B-Interim-report-2-7-July-2020.pdf

Preview of 7 July – LUCID-B study: Interim report 2

🔗 Source: arc-w.nihr.ac.uk

📊 Size: 216 KB

👤 Author: Adam Holland

⬇️ Downloads: 79

Summary

The LUCID-B study examines how people in Bristol who inject drugs are affected by the COVID-19 pandemic. Interim Report 2 summarizes findings from 6 interviews conducted between June 23rd and July 3rd, 2020. Key issues identified include challenges accessing needle and syringe programs, pharmacies, and information about services. Participants reported mixed experiences with drug quality and supply, and many did not take COVID-19 prevention measures. The majority reported using drugs less frequently or in smaller amounts due to financial difficulties. Some participants appreciated the convenience of phone-based shared care worker appointments, while others missed face-to-face interactions. The report highlights areas for further consideration and research, including the need for improved information access, COVID-19 testing, and support for people experiencing homelessness and financial difficulties.

Download File

Description

The LUCID-B study examines how people in Bristol who inject drugs are affected by the COVID-19 pandemic.

Technical Information

File Format: PDF
File Size: 216 KB
Pages: 5
Language: EN
Author: Adam Holland
Total Downloads: 79
Last Updated: 4 weeks ago

Document Overview

This PDF document about 7 July – LUCID-B study: Interim report 2 provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into 7 July – LUCID-B study: Interim report 2.